UK markets close in 3 hours 58 minutes

LAVA Therapeutics N.V. (LVTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.6400-0.1000 (-3.65%)
At close: 04:00PM EDT
2.5700 -0.07 (-2.65%)
After hours: 05:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,769
6,769
19,391
5,350
3,747
Cost of revenue
3,482
3,482
0
0
-
Gross profit
3,287
3,287
19,391
5,350
-
Operating expenses
Research development
33,814
33,814
40,105
36,945
15,701
Selling general and administrative
12,726
12,726
14,124
12,018
2,719
Total operating expenses
46,540
46,540
54,229
48,963
18,420
Operating income or loss
-43,253
-43,253
-34,838
-43,613
-14,673
Interest expense
232
232
82
625
342
Total other income/expenses net
-1,412
-1,412
2,923
2,040
-869
Income before tax
-41,695
-41,695
-31,658
-42,198
-15,884
Income tax expense
279
279
249
157
43
Income from continuing operations
-41,974
-41,974
-31,907
-42,355
-15,927
Net income
-41,974
-41,974
-31,907
-42,355
-15,927
Net income available to common shareholders
-41,974
-41,974
-31,907
-42,355
-15,927
Basic EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Diluted EPS
-1.92
-1.57
-1.23
-2.14
-0.63
Basic average shares
26,290
26,733
25,924
19,758
25,352
Diluted average shares
26,290
26,733
25,924
19,758
25,352